SURVYR
Third-party analyst actions

Analyst moves

Upgrades, downgrades, new coverage and price-target changes from Wall Street firms on the stocks we cover. What each firm published, laid out plainly. These are third-party actions, not our views.

Try one

188 moves · this week

ⓘ Rating colors
  • Strong BuyConviction Buy, Top Pick, Top Pick Buy
  • BuyLong Term Buy, Speculative Buy, Outright Buy
  • OutperformOverweight, Accumulate, Moderate Buy, Positive
  • HoldNeutral, Equal Weight, Market Perform, Sector Perform
  • UnderperformUnderweight, Reduce, Moderate Sell, Negative
  • Sell
  • Strong Sell
  • OtherRatings we can't place on the scale

Each firm's own wording is placed on one seven-step scale so ratings compare at a glance. ▲ / ▼ between two ratings marks an upgrade or a downgrade. The colours describe what the firm said; they are not our view.

Today · Oct 27, 2026

Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$526 → $487 −7.4% · −$39
Price at note$410.39 (Oct 27 close) +18.7% upside (+$76.61) to the $487 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$529 → $531 +0.4% · +$2
Price at note$410.39 (Oct 27 close) +29.4% upside (+$120.61) to the $531 target
B of A Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$368 → $330 −10.3% · −$38
Price at note$201.28 (Oct 27 close) +64.0% upside (+$128.72) to the $330 target
TLNTalen EnergyOur stock$345.73
Barclays Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$408 → $387 −5.1% · −$21
Price at note$345.73 (Oct 27 close) +11.9% upside (+$41.27) to the $387 target
Rosenblatt Reiterated▲ Target raised
RatingBuy unchanged
Price target$225 → $260 +15.6% · +$35
Price at note$198.73 (Oct 27 close) +30.8% upside (+$61.27) to the $260 target
PAYCPaycomOur stock$261.94
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$194 → $279 +43.8% · +$85
Price at note$261.94 (Oct 27 close) +6.5% upside (+$17.06) to the $279 target
PAYCPaycomOur stock$261.94
Jefferies Reiterated▲ Target raised
RatingHold unchanged
Price target$160 → $300 +87.5% · +$140
Price at note$261.94 (Oct 27 close) +14.5% upside (+$38.06) to the $300 target
Citigroup ▲ Upgrade▼ Target lowered
RatingNeutral▲Buy
Price target$2,100 → $2,050 −2.4% · −$50
Price at note$1,680.51 (Oct 27 close) +22.0% upside (+$369.49) to the $2,050 target
BNP Paribas Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$43 → $35 −18.6% · −$8
Price at note$16.98 (Oct 27 close) +106.1% upside (+$18.02) to the $35 target
Susquehanna Reiterated▲ Target raised
RatingPositive unchanged
Price target$55 → $60 +9.1% · +$5
Price at note$52.27 (Oct 27 close) +14.8% upside (+$7.73) to the $60 target
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$56 → $46 −17.9% · −$10
Price at note$38.53 (Oct 27 close) +19.4% upside (+$7.47) to the $46 target
CEGConstellation EnergyOur stock$258.98
TD Cowen Reiterated▲ Target raised
RatingBuy unchanged
Price target$368 → $374 +1.6% · +$6
Price at note$258.98 (Oct 27 close) +44.4% upside (+$115.02) to the $374 target
CEGConstellation EnergyOur stock$258.98
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$324 → $345 +6.5% · +$21
Price at note$258.98 (Oct 27 close) +33.2% upside (+$86.02) to the $345 target
BMO Capital Reiterated▼ Target lowered
RatingMarket Perform unchanged
Price target$134 → $124 −7.5% · −$10
Price at note$114.26 (Oct 27 close) +8.5% upside (+$9.74) to the $124 target

Yesterday · Oct 26, 2026

Barclays ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$370 → $450 +21.6% · +$80
Price at note$391.62 (Oct 26 close) +14.9% upside (+$58.38) to the $450 target
HC Wainwright & Co. Reiterated▲ Target raised
RatingBuy unchanged
Price target$66 → $68 +3.0% · +$2
Price at note$67.16 (Oct 26 close) +1.3% upside (+$0.84) to the $68 target
Rosenblatt Reiterated▲ Target raised
RatingBuy unchanged
Price target$80 → $105 +31.2% · +$25
Price at note$86.31 (Oct 26 close) +21.7% upside (+$18.69) to the $105 target
PAYCPaycomOur stock$261.94
BTIG Reiterated▲ Target raised
RatingBuy unchanged
Price target$230 → $305 +32.6% · +$75
Price at note$268.25 (Oct 26 close) +13.7% upside (+$36.75) to the $305 target
Cantor Fitzgerald Reiterated▲ Target raised
RatingOverweight unchanged
Price target$174 → $201 +15.5% · +$27
Price at note$158.18 (Oct 26 close) +27.1% upside (+$42.82) to the $201 target
LOWLowe's$198.18
Stifel Reiterated▼ Target lowered
RatingHold unchanged
Price target$220 → $195 −11.4% · −$25
Price at note$198.22 (Oct 26 close) −1.6% downside (−$3.22) to the $195 target
JP Morgan Reiterated▲ Target raised
RatingNeutral unchanged
Price target$620 → $665 +7.3% · +$45
Price at note$635.20 (Oct 26 close) +4.7% upside (+$29.80) to the $665 target
Morgan Stanley ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$690 → $835 +21.0% · +$145
Price at note$635.20 (Oct 26 close) +31.5% upside (+$199.80) to the $835 target
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$82 → $64 −22.0% · −$18
Price at note$40.33 (Oct 26 close) +58.7% upside (+$23.67) to the $64 target
Goldman Sachs Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$15 → $6 −60.0% · −$9
Price at note$7.01 (Oct 26 close) −14.4% downside (−$1.01) to the $6 target
FIXComfort Systems USAOur stock$1,288.61
UBS Reiterated▼ Target lowered
RatingBuy unchanged
Price target$2,225 → $1,900 −14.6% · −$325
Price at note$1,244.19 (Oct 26 close) +52.7% upside (+$655.81) to the $1,900 target
FIXComfort Systems USAOur stock$1,288.61
Oppenheimer Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$2,400 → $2,000 −16.7% · −$400
Price at note$1,244.19 (Oct 26 close) +60.7% upside (+$755.81) to the $2,000 target
FIXComfort Systems USAOur stock$1,288.61
Keybanc Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$2,125 → $1,979 −6.9% · −$146
Price at note$1,244.19 (Oct 26 close) +59.1% upside (+$734.81) to the $1,979 target
FICOFair IsaacOur stock$691.74
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$1,100 → $942 −14.4% · −$158
Price at note$708.07 (Oct 26 close) +33.0% upside (+$233.93) to the $942 target
FICOFair IsaacOur stock$691.74
BMO Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$1,150 → $897 −22.0% · −$253
Price at note$708.07 (Oct 26 close) +26.7% upside (+$188.93) to the $897 target
FICOFair IsaacOur stock$691.74
JP Morgan Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$1,530 → $900 −41.2% · −$630
Price at note$708.07 (Oct 26 close) +27.1% upside (+$191.93) to the $900 target
FICOFair IsaacOur stock$691.74
Wells Fargo ▼ Downgrade▼ Target lowered
RatingOverweight▼Equal-Weight
Price target$800 → $735 −8.1% · −$65
Price at note$708.07 (Oct 26 close) +3.8% upside (+$26.93) to the $735 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$25 → $19 −24.0% · −$6
Price at note$16.26 (Oct 26 close) +16.9% upside (+$2.74) to the $19 target
GLJ Research Reiterated▼ Target lowered
RatingSell unchanged
Price target$24.47 → $21.49 −12.2% · −$2.98
Price at note$31.60 (Oct 23 close, before the note) −32.0% downside (−$10.11) to the $21.49 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$125 → $105 −16.0% · −$20
Price at note$99.53 (Oct 26 close) +5.5% upside (+$5.47) to the $105 target
Morgan Stanley Reiterated▲ Target raised
RatingUnderweight unchanged
Price target$76 → $83 +9.2% · +$7
Price at note$94.41 (Oct 26 close) −12.1% downside (−$11.41) to the $83 target
JP Morgan Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$52 → $48 −7.7% · −$4
Price at note$28.15 (Oct 26 close) +70.5% upside (+$19.85) to the $48 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$925 → $750 −18.9% · −$175
Price at note$692.13 (Oct 26 close) +8.4% upside (+$57.87) to the $750 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$1,155 → $840 −27.3% · −$315
Price at note$692.13 (Oct 26 close) +21.4% upside (+$147.87) to the $840 target
BSXBoston ScientificOur stock$45.06
Stifel Reiterated▼ Target lowered
RatingBuy unchanged
Price target$60 → $55 −8.3% · −$5
Price at note$45.58 (Oct 26 close) +20.7% upside (+$9.42) to the $55 target
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$77 → $88 +14.3% · +$11
Price at note$83.36 (Oct 26 close) +5.6% upside (+$4.64) to the $88 target
BNP Paribas Reiterated▲ Target raised
RatingNeutral unchanged
Price target$70 → $85 +21.4% · +$15
Price at note$83.36 (Oct 26 close) +2.0% upside (+$1.64) to the $85 target
TD Cowen ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$77 → $95 +23.4% · +$18
Price at note$83.36 (Oct 26 close) +14.0% upside (+$11.64) to the $95 target
Morgan Stanley Reiterated▼ Target lowered
RatingEqual-Weight unchanged
Price target$82 → $79 −3.7% · −$3
Price at note$69.49 (Oct 26 close) +13.7% upside (+$9.51) to the $79 target

Friday · Oct 23, 2026

RBC Capital Reiterated▲ Target raised
RatingSector Perform unchanged
Price target$92 → $96 +4.3% · +$4
Price at note$112.49 (Oct 23 close) −14.7% downside (−$16.49) to the $96 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$1,395 → $1,450 +3.9% · +$55
Price at note$1,098.88 (Oct 23 close) +32.0% upside (+$351.12) to the $1,450 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$1,335 → $1,350 +1.1% · +$15
Price at note$1,098.88 (Oct 23 close) +22.9% upside (+$251.12) to the $1,350 target
RBC Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$1,323 → $1,392 +5.2% · +$69
Price at note$1,098.88 (Oct 23 close) +26.7% upside (+$293.12) to the $1,392 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$110 → $112 +1.8% · +$2
Price at note$104.20 (Oct 23 close) +7.5% upside (+$7.80) to the $112 target
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$640 → $700 +9.4% · +$60
Price at note$584.22 (Oct 23 close) +19.8% upside (+$115.78) to the $700 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$550 → $650 +18.2% · +$100
Price at note$584.22 (Oct 23 close) +11.3% upside (+$65.78) to the $650 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$540 → $580 +7.4% · +$40
Price at note$584.22 (Oct 23 close) −0.7% downside (−$4.22) to the $580 target
JP Morgan Reiterated▲ Target raised
RatingOverweight unchanged
Price target$650 → $700 +7.7% · +$50
Price at note$584.22 (Oct 23 close) +19.8% upside (+$115.78) to the $700 target
Evercore ISI Group Reiterated▲ Target raised
RatingOutperform unchanged
Price target$700 → $750 +7.1% · +$50
Price at note$584.22 (Oct 23 close) +28.4% upside (+$165.78) to the $750 target
Wells Fargo Reiterated▲ Target raised
RatingOverweight unchanged
Price target$570 → $660 +15.8% · +$90
Price at note$584.22 (Oct 23 close) +13.0% upside (+$75.78) to the $660 target
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$565 → $650 +15.0% · +$85
Price at note$584.22 (Oct 23 close) +11.3% upside (+$65.78) to the $650 target
Rosenblatt Reiterated▲ Target raised
RatingNeutral unchanged
Price target$527 → $576 +9.3% · +$49
Price at note$584.22 (Oct 23 close) −1.4% downside (−$8.22) to the $576 target
Cantor Fitzgerald Reiterated▲ Target raised
RatingNeutral unchanged
Price target$490 → $550 +12.2% · +$60
Price at note$584.22 (Oct 23 close) −5.9% downside (−$34.22) to the $550 target
Mizuho Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$115 → $105 −8.7% · −$10
Price at note$100.80 (Oct 23 close) +4.2% upside (+$4.20) to the $105 target
Jefferies Reiterated▲ Target raised
RatingHold unchanged
Price target$40 → $75 +87.5% · +$35
Price at note$83.39 (Oct 23 close) −10.1% downside (−$8.39) to the $75 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$45 → $105 +133.3% · +$60
Price at note$83.39 (Oct 23 close) +25.9% upside (+$21.61) to the $105 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$85 → $110 +29.4% · +$25
Price at note$83.39 (Oct 23 close) +31.9% upside (+$26.61) to the $110 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$43 → $94 +118.6% · +$51
Price at note$83.39 (Oct 23 close) +12.7% upside (+$10.61) to the $94 target
Evercore ISI Group Reiterated▲ Target raised
RatingIn-Line unchanged
Price target$38 → $90 +136.8% · +$52
Price at note$83.39 (Oct 23 close) +7.9% upside (+$6.61) to the $90 target
Wells Fargo Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$65 → $85 +30.8% · +$20
Price at note$83.39 (Oct 23 close) +1.9% upside (+$1.61) to the $85 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$41 → $91 +122.0% · +$50
Price at note$83.39 (Oct 23 close) +9.1% upside (+$7.61) to the $91 target
Needham Reiterated▲ Target raised
RatingBuy unchanged
Price target$85 → $110 +29.4% · +$25
Price at note$83.39 (Oct 23 close) +31.9% upside (+$26.61) to the $110 target
Truist Securities Reiterated▲ Target raised
RatingHold unchanged
Price target$53 → $58 +9.4% · +$5
Price at note$57.02 (Oct 23 close) +1.7% upside (+$0.98) to the $58 target
Piper Sandler Reiterated▲ Target raised
RatingOverweight unchanged
Price target$230 → $231 +0.4% · +$1
Price at note$196.75 (Oct 23 close) +17.4% upside (+$34.25) to the $231 target
PAYCPaycomOur stock$261.94
Guggenheim Reiterated▲ Target raised
RatingBuy unchanged
Price target$225 → $300 +33.3% · +$75
Price at note$274.59 (Oct 23 close) +9.3% upside (+$25.41) to the $300 target
Guggenheim Reiterated▲ Target raised
RatingBuy unchanged
Price target$125 → $175 +40.0% · +$50
Price at note$158.96 (Oct 23 close) +10.1% upside (+$16.04) to the $175 target
Jefferies ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$130 → $135 +3.8% · +$5
Price at note$113.86 (Oct 23 close) +18.6% upside (+$21.14) to the $135 target
Keybanc Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$145 → $140 −3.4% · −$5
Price at note$113.86 (Oct 23 close) +23.0% upside (+$26.14) to the $140 target
Stephens & Co. ▲ Upgrade▲ Target raised
RatingEqual-Weight▲Overweight
Price target$130 → $135 +3.8% · +$5
Price at note$113.86 (Oct 23 close) +18.6% upside (+$21.14) to the $135 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$633 → $674 +6.5% · +$41
Price at note$623.60 (Oct 23 close) +8.1% upside (+$50.40) to the $674 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$653 → $692 +6.0% · +$39
Price at note$604.18 (Oct 23 close) +14.5% upside (+$87.82) to the $692 target
Citigroup Reiterated▲ Target raised
RatingBuy unchanged
Price target$691 → $706 +2.2% · +$15
Price at note$604.18 (Oct 23 close) +16.9% upside (+$101.82) to the $706 target
RBC Capital Reiterated▲ Target raised
RatingSector Perform unchanged
Price target$550 → $600 +9.1% · +$50
Price at note$604.18 (Oct 23 close) −0.7% downside (−$4.18) to the $600 target
Barclays Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$554 → $560 +1.1% · +$6
Price at note$604.18 (Oct 23 close) −7.3% downside (−$44.18) to the $560 target
Freedom Broker ▲ Upgrade▼ Target lowered
RatingHold▲Buy
Price target$1,200 → $1,100 −8.3% · −$100
Price at note$875.68 (Oct 23 close) +25.6% upside (+$224.32) to the $1,100 target
Truist Securities Reiterated▼ Target lowered
RatingHold unchanged
Price target$95 → $86 −9.5% · −$9
Price at note$82.82 (Oct 23 close) +3.8% upside (+$3.18) to the $86 target
Piper Sandler Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$303 → $279 −7.9% · −$24
Price at note$186.92 (Oct 23 close) +49.3% upside (+$92.08) to the $279 target
FTNTFortinetOur stock$185.00
JP Morgan Reiterated▲ Target raised
RatingUnderweight unchanged
Price target$118 → $140 +18.6% · +$22
Price at note$179.99 (Oct 23 close) −22.2% downside (−$39.99) to the $140 target
Canaccord Genuity Reiterated▼ Target lowered
RatingBuy unchanged
Price target$265 → $250 −5.7% · −$15
Price at note$172.75 (Oct 23 close) +44.7% upside (+$77.25) to the $250 target
TD Cowen Reiterated▼ Target lowered
RatingBuy unchanged
Price target$242 → $235 −2.9% · −$7
Price at note$172.75 (Oct 23 close) +36.0% upside (+$62.25) to the $235 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$48 → $50 +4.2% · +$2
Price at note$33.21 (Oct 23 close) +50.6% upside (+$16.79) to the $50 target
Barclays Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$53 → $51 −3.8% · −$2
Price at note$33.21 (Oct 23 close) +53.6% upside (+$17.79) to the $51 target
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$53 → $54 +1.9% · +$1
Price at note$50.79 (Oct 23 close) +6.3% upside (+$3.21) to the $54 target
Evercore ISI Group Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$47 → $40 −14.9% · −$7
Price at note$27.52 (Oct 23 close) +45.3% upside (+$12.48) to the $40 target
Mizuho Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$43 → $37 −14.0% · −$6
Price at note$27.52 (Oct 23 close) +34.4% upside (+$9.48) to the $37 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$116 → $118 +1.7% · +$2
Price at note$117.97 (Oct 23 close) +0.0% upside (+$0.03) to the $118 target
Oppenheimer Reiterated▲ Target raised
RatingOutperform unchanged
Price target$164 → $168 +2.4% · +$4
Price at note$117.97 (Oct 23 close) +42.4% upside (+$50.03) to the $168 target
Piper Sandler Reiterated▲ Target raised
RatingNeutral unchanged
Price target$125 → $126 +0.8% · +$1
Price at note$117.97 (Oct 23 close) +6.8% upside (+$8.03) to the $126 target
JP Morgan Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$136 → $135 −0.7% · −$1
Price at note$117.97 (Oct 23 close) +14.4% upside (+$17.03) to the $135 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$85 → $88 +3.5% · +$3
Price at note$70.08 (Oct 23 close) +25.6% upside (+$17.92) to the $88 target
ABBVAbbVie$286.39
Goldman Sachs Reiterated▲ Target raised
RatingNeutral unchanged
Price target$258 → $294 +14.0% · +$36
Price at note$285.64 (Oct 23 close) +2.9% upside (+$8.36) to the $294 target

Thursday · Oct 22, 2026

Freedom Broker Reiterated▲ Target raised
RatingBuy unchanged
Price target$230 → $270 +17.4% · +$40
Price at note$212.53 (Oct 19 close, before the note) +27.0% upside (+$57.47) to the $270 target
RBC Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$708 → $697 −1.6% · −$11
Price at note$584.79 (Oct 22 close) +19.2% upside (+$112.21) to the $697 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$1,350 → $1,450 +7.4% · +$100
Price at note$1,111.02 (Oct 22 close) +30.5% upside (+$338.98) to the $1,450 target
Mizuho Reiterated▲ Target raised
RatingOutperform unchanged
Price target$493 → $500 +1.4% · +$7
Price at note$424.98 (Oct 22 close) +17.7% upside (+$75.02) to the $500 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$391 → $425 +8.7% · +$34
Price at note$374.58 (Oct 22 close) +13.5% upside (+$50.42) to the $425 target
CLSA ▲ Upgrade▲ Target raised
RatingUnderperform▲Hold
Price target$310 → $400 +29.0% · +$90
Price at note$374.58 (Oct 22 close) +6.8% upside (+$25.42) to the $400 target
Canaccord Genuity Reiterated▲ Target raised
RatingBuy unchanged
Price target$410 → $442 +7.8% · +$32
Price at note$374.58 (Oct 22 close) +18.0% upside (+$67.42) to the $442 target
Morgan Stanley Reiterated▲ Target raised
RatingEqual-Weight unchanged
Price target$400 → $410 +2.5% · +$10
Price at note$374.58 (Oct 22 close) +9.5% upside (+$35.42) to the $410 target
BNP Paribas ▲ Upgrade▲ Target raised
RatingUnderperform▲Neutral
Price target$266 → $420 +57.9% · +$154
Price at note$374.58 (Oct 22 close) +12.1% upside (+$45.42) to the $420 target
JP Morgan Reiterated▲ Target raised
RatingNeutral unchanged
Price target$415 → $430 +3.6% · +$15
Price at note$374.58 (Oct 22 close) +14.8% upside (+$55.42) to the $430 target
Piper Sandler Reiterated▲ Target raised
RatingOverweight unchanged
Price target$450 → $475 +5.6% · +$25
Price at note$374.58 (Oct 22 close) +26.8% upside (+$100.42) to the $475 target
Mizuho Reiterated▲ Target raised
RatingOutperform unchanged
Price target$450 → $460 +2.2% · +$10
Price at note$374.58 (Oct 22 close) +22.8% upside (+$85.42) to the $460 target
B. Riley Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$225 → $195 −13.3% · −$30
Price at note$128.89 (Oct 22 close) +51.3% upside (+$66.11) to the $195 target
Citigroup Reiterated▲ Target raised
RatingBuy unchanged
Price target$245 → $250 +2.0% · +$5
Price at note$196.19 (Oct 22 close) +27.4% upside (+$53.81) to the $250 target
Argus Research Reiterated▼ Target lowered
RatingBuy unchanged
Price target$120 → $95 −20.8% · −$25
Price at note$67.05 (Oct 22 close) +41.7% upside (+$27.95) to the $95 target
Pivotal Research Reiterated▼ Target lowered
RatingHold unchanged
Price target$70 → $65 −7.1% · −$5
Price at note$67.05 (Oct 22 close) −3.1% downside (−$2.05) to the $65 target
Freedom Broker Reiterated▼ Target lowered
RatingBuy unchanged
Price target$80 → $76 −5.0% · −$4
Price at note$57.62 (Oct 21 close, before the note) +31.9% upside (+$18.38) to the $76 target
B. Riley Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$108 → $98 −9.3% · −$10
Price at note$74.52 (Oct 22 close) +31.5% upside (+$23.48) to the $98 target
Freedom Broker ▲ Upgrade▲ Target raised
RatingHold▲Buy
Price target$37 → $40 +8.1% · +$3
Price at note$33.19 (Oct 22 close) +20.5% upside (+$6.81) to the $40 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$42 → $41 −2.4% · −$1
Price at note$33.19 (Oct 22 close) +23.5% upside (+$7.81) to the $41 target
Citizens Reiterated▼ Target lowered
RatingMarket Outperform unchanged
Price target$24 → $14 −41.7% · −$10
Price at note$7.24 (Oct 22 close) +93.4% upside (+$6.76) to the $14 target
Mizuho Reiterated▲ Target raised
RatingNeutral unchanged
Price target$42 → $44 +4.8% · +$2
Price at note$33.11 (Oct 22 close) +32.9% upside (+$10.89) to the $44 target
UBS Reiterated▲ Target raised
RatingBuy unchanged
Price target$54 → $60 +11.1% · +$6
Price at note$51.67 (Oct 22 close) +16.1% upside (+$8.33) to the $60 target
B of A Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$55 → $57 +3.6% · +$2
Price at note$51.67 (Oct 22 close) +10.3% upside (+$5.33) to the $57 target
RBC Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$53 → $54 +1.9% · +$1
Price at note$51.67 (Oct 22 close) +4.5% upside (+$2.33) to the $54 target
TD Cowen Reiterated▲ Target raised
RatingBuy unchanged
Price target$54 → $55 +1.9% · +$1
Price at note$51.67 (Oct 22 close) +6.4% upside (+$3.33) to the $55 target
JP Morgan Reiterated▲ Target raised
RatingOverweight unchanged
Price target$57 → $58 +1.8% · +$1
Price at note$51.67 (Oct 22 close) +12.3% upside (+$6.33) to the $58 target
UBS Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$148 → $100 −32.4% · −$48
Price at note$91.13 (Oct 22 close) +9.7% upside (+$8.87) to the $100 target

Wednesday · Oct 21, 2026

BMO Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$303 → $328 +8.3% · +$25
Price at note$295.60 (Oct 21 close) +11.0% upside (+$32.40) to the $328 target
TLNTalen EnergyOur stock$345.73
Morgan Stanley Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$514 → $504 −1.9% · −$10
Price at note$359.49 (Oct 21 close) +40.2% upside (+$144.51) to the $504 target
SMCISupermicroOur stock$35.09
Rosenblatt Reiterated▲ Target raised
RatingBuy unchanged
Price target$51 → $57 +11.8% · +$6
Price at note$35.57 (Oct 21 close) +60.2% upside (+$21.43) to the $57 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$125 → $120 −4.0% · −$5
Price at note$99.08 (Oct 21 close) +21.1% upside (+$20.92) to the $120 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$209 → $212 +1.4% · +$3
Price at note$191.60 (Oct 21 close) +10.6% upside (+$20.40) to the $212 target
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$223 → $235 +5.4% · +$12
Price at note$191.60 (Oct 21 close) +22.7% upside (+$43.40) to the $235 target
Keefe, Bruyette & Woods Reiterated▲ Target raised
RatingOutperform unchanged
Price target$69 → $74 +7.2% · +$5
Price at note$63.90 (Oct 21 close) +15.8% upside (+$10.10) to the $74 target
Wells Fargo Reiterated▲ Target raised
RatingUnderweight unchanged
Price target$51 → $53 +3.9% · +$2
Price at note$63.90 (Oct 21 close) −17.1% downside (−$10.90) to the $53 target
Truist Securities Reiterated▲ Target raised
RatingBuy unchanged
Price target$130 → $180 +38.5% · +$50
Price at note$153.12 (Oct 21 close) +17.6% upside (+$26.88) to the $180 target
UBS Reiterated▼ Target lowered
RatingBuy unchanged
Price target$115 → $100 −13.0% · −$15
Price at note$65.04 (Oct 21 close) +53.8% upside (+$34.96) to the $100 target
Citigroup Reiterated▼ Target lowered
RatingBuy unchanged
Price target$100 → $85 −15.0% · −$15
Price at note$65.04 (Oct 21 close) +30.7% upside (+$19.96) to the $85 target
Oppenheimer Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$85 → $80 −5.9% · −$5
Price at note$65.04 (Oct 21 close) +23.0% upside (+$14.96) to the $80 target
Morgan Stanley Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$80 → $77 −3.8% · −$3
Price at note$65.04 (Oct 21 close) +18.4% upside (+$11.96) to the $77 target
JP Morgan Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$85 → $81 −4.7% · −$4
Price at note$65.04 (Oct 21 close) +24.5% upside (+$15.96) to the $81 target
Piper Sandler Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$85 → $78 −8.2% · −$7
Price at note$65.04 (Oct 21 close) +19.9% upside (+$12.96) to the $78 target
Evercore ISI Group Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$110 → $90 −18.2% · −$20
Price at note$65.04 (Oct 21 close) +38.4% upside (+$24.96) to the $90 target
Barclays Reiterated▼ Target lowered
RatingEqual-Weight unchanged
Price target$70 → $65 −7.1% · −$5
Price at note$65.04 (Oct 21 close) −0.1% downside (−$0.04) to the $65 target
Guggenheim Reiterated▼ Target lowered
RatingBuy unchanged
Price target$80 → $78 −2.5% · −$2
Price at note$65.04 (Oct 21 close) +19.9% upside (+$12.96) to the $78 target
Wedbush Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$90 → $80 −11.1% · −$10
Price at note$65.04 (Oct 21 close) +23.0% upside (+$14.96) to the $80 target
Bernstein Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$95 → $80 −15.8% · −$15
Price at note$65.04 (Oct 21 close) +23.0% upside (+$14.96) to the $80 target
Rosenblatt Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$75 → $71 −5.3% · −$4
Price at note$65.04 (Oct 21 close) +9.2% upside (+$5.96) to the $71 target
B of A Securities Reiterated▼ Target lowered
RatingBuy unchanged
Price target$105 → $90 −14.3% · −$15
Price at note$65.04 (Oct 21 close) +38.4% upside (+$24.96) to the $90 target
NBISNebius Group N.V.Our stock$170.47
Piper Sandler Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$237 → $185 −21.9% · −$52
Price at note$171.57 (Oct 21 close) +7.8% upside (+$13.43) to the $185 target
Citigroup Reiterated▲ Target raised
RatingNeutral unchanged
Price target$225 → $230 +2.2% · +$5
Price at note$215.28 (Oct 16 close, before the note) +6.8% upside (+$14.72) to the $230 target
ISRGIntuitive SurgicalOur stock$445.88
Leerink Partners Reiterated▲ Target raised
RatingOutperform unchanged
Price target$473 → $503 +6.3% · +$30
Price at note$428.12 (Oct 21 close) +17.5% upside (+$74.88) to the $503 target
ISRGIntuitive SurgicalOur stock$445.88
JP Morgan Reiterated▲ Target raised
RatingOverweight unchanged
Price target$450 → $475 +5.6% · +$25
Price at note$428.12 (Oct 21 close) +11.0% upside (+$46.88) to the $475 target
ISRGIntuitive SurgicalOur stock$445.88
Evercore ISI Group Reiterated▼ Target lowered
RatingIn-Line unchanged
Price target$400 → $385 −3.8% · −$15
Price at note$428.12 (Oct 21 close) −10.1% downside (−$43.12) to the $385 target
ISRGIntuitive SurgicalOur stock$445.88
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$487 → $486 −0.2% · −$1
Price at note$428.12 (Oct 21 close) +13.5% upside (+$57.88) to the $486 target
ISRGIntuitive SurgicalOur stock$445.88
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$485 → $500 +3.1% · +$15
Price at note$428.12 (Oct 21 close) +16.8% upside (+$71.88) to the $500 target
ISRGIntuitive SurgicalOur stock$445.88
RBC Capital Reiterated▼ Target lowered
RatingOutperform unchanged
Price target$575 → $550 −4.3% · −$25
Price at note$428.12 (Oct 21 close) +28.5% upside (+$121.88) to the $550 target
ISRGIntuitive SurgicalOur stock$445.88
Mizuho Reiterated▼ Target lowered
RatingNeutral unchanged
Price target$415 → $400 −3.6% · −$15
Price at note$428.12 (Oct 21 close) −6.6% downside (−$28.12) to the $400 target
ISRGIntuitive SurgicalOur stock$445.88
Baird Reiterated▲ Target raised
RatingOutperform unchanged
Price target$513 → $550 +7.2% · +$37
Price at note$428.12 (Oct 21 close) +28.5% upside (+$121.88) to the $550 target
INCYIncyteOur stock$116.60
TD Cowen Reiterated▲ Target raised
RatingBuy unchanged
Price target$138 → $140 +1.4% · +$2
Price at note$113.44 (Oct 21 close) +23.4% upside (+$26.56) to the $140 target
Jefferies Reiterated▲ Target raised
RatingBuy unchanged
Price target$47 → $48 +2.1% · +$1
Price at note$33.99 (Oct 21 close) +41.2% upside (+$14.01) to the $48 target
Barclays Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$53 → $51 −3.8% · −$2
Price at note$33.99 (Oct 21 close) +50.0% upside (+$17.01) to the $51 target
RBC Capital Reiterated▲ Target raised
RatingOutperform unchanged
Price target$45 → $46 +2.2% · +$1
Price at note$33.99 (Oct 21 close) +35.3% upside (+$12.01) to the $46 target
Guggenheim Reiterated▼ Target lowered
RatingBuy unchanged
Price target$28 → $17 −39.3% · −$11
Price at note$7.07 (Oct 21 close) +140.5% upside (+$9.93) to the $17 target
BMO Capital Reiterated▼ Target lowered
RatingMarket Perform unchanged
Price target$37 → $28 −24.3% · −$9
Price at note$31.99 (Oct 21 close) −12.5% downside (−$3.99) to the $28 target
Piper Sandler ▲ Upgrade▼ Target lowered
RatingNeutral▲Overweight
Price target$142 → $126 −11.3% · −$16
Price at note$101.48 (Oct 21 close) +24.2% upside (+$24.52) to the $126 target
Wells Fargo Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$45 → $40 −11.1% · −$5
Price at note$28.12 (Oct 21 close) +42.2% upside (+$11.88) to the $40 target
TD Cowen ▼ Downgrade▼ Target lowered
RatingBuy▼Hold
Price target$44 → $32 −27.3% · −$12
Price at note$28.12 (Oct 21 close) +13.8% upside (+$3.88) to the $32 target
CEGConstellation EnergyOur stock$258.98
Morgan Stanley Reiterated▲ Target raised
RatingOverweight unchanged
Price target$369 → $378 +2.4% · +$9
Price at note$270.74 (Oct 21 close) +39.6% upside (+$107.26) to the $378 target
UBS Reiterated▲ Target raised
RatingNeutral unchanged
Price target$116 → $118 +1.7% · +$2
Price at note$116.22 (Oct 21 close) +1.5% upside (+$1.78) to the $118 target
Citigroup Reiterated▲ Target raised
RatingBuy unchanged
Price target$137 → $139 +1.5% · +$2
Price at note$116.22 (Oct 21 close) +19.6% upside (+$22.78) to the $139 target
Citizens Reiterated▲ Target raised
RatingMarket Outperform unchanged
Price target$52 → $68 +30.8% · +$16
Price at note$57.67 (Oct 21 close) +17.9% upside (+$10.33) to the $68 target
Piper Sandler Reiterated▼ Target lowered
RatingOverweight unchanged
Price target$158 → $120 −24.1% · −$38
Price at note$90.27 (Oct 21 close) +32.9% upside (+$29.73) to the $120 target
ABBVAbbVie$286.39
Barclays Reiterated▲ Target raised
RatingOverweight unchanged
Price target$300 → $325 +8.3% · +$25
Price at note$284.80 (Oct 21 close) +14.1% upside (+$40.20) to the $325 target

Source: Yahoo Finance analyst upgrades and downgrades (firm, rating, price target), refreshed after each US market close for the stocks SURVYR. covers. Yahoo doesn't name the individual analyst. "Price at note" is that day's closing price from our daily price history (the prior close when the note came before the open); the upside or downside is the distance from it to the new target. Details opens the matching news story when we have one, otherwise the stock's Yahoo Finance analysis page. Ratings and targets belong to the firms named; SURVYR. doesn't rate stocks, set targets or give advice. Not investment advice · Important disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026